Prompt Vitrectomy Plus Panretinal Photocoagulation: Clinical Trials

1 trial of Prompt Vitrectomy Plus Panretinal Photocoagulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Prompt Vitrectomy Plus Panretinal Photocoagulation: new trials by email Literature Review of Prompt Vitrectomy Plus Panretinal Photocoagulation trials Research Report on Prompt Vitrectomy Plus Panretinal Photocoagulation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
2-mg Intravitreous Aflibercept Injection, Prompt Vitrectomy Plus Panretinal Photocoagulation - Proliferative Diabetic Retinopathy, Vitreous Hemorrhage
Phase 2 / Phase 3CompletedJaeb Center for Health Research2052016-11-012021-04-20

Conditions studied

Vitreous Hemorrhage (1)

Sponsors

Jaeb Center for Health Research (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Andrew Antoszyk, MD (1)

Results publications

PMID 33320223, PMID 33956075, PMID 37972038